BODI vs LRHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

BODI

64.4
AI Score
VS
BODI Wins

LRHC

36.5
AI Score

Investment Advisor Scores

BODI

64score
Recommendation
BUY

LRHC

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BODI LRHC Winner
Revenue 103.90M 20.32M BODI
Net Income 3.67M -1.74M BODI
Gross Margin 71.9% 9.2% BODI
Net Margin 3.5% -8.5% BODI
Operating Income 4.78M -1.12M BODI
ROE 9.9% -240.3% BODI
ROA 2.7% -30.1% BODI
Total Assets 136.51M 5.77M BODI
Cash 32.39M 350,276 BODI
Current Ratio 0.79 0.72 BODI

Relative Price Performance (Last 90 Days)

BODI 1M: -15.6% · 3M: -51.4% LRHC 1M: +267.1% · 3M: +44.4%

Current Technical Phase

BODI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -24.8%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $4.92

LRHC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.4 · Price: $1.56

Fundamentals Snapshot

Metric BODI LRHC
Market Cap — —
Forward P/E 54.7 0.0
Trailing P/E 2.6 —
Revenue (TTM) — —
Revenue Growth -0.2% -0.3%
Gross Margin 0.7% 0.1%
Operating Margin 0.0% -0.1%
EPS 1.82 -18911.96
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.